U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H24O12
Molecular Weight 516.4509
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of 3,5-DI-O-CAFFEOYLQUINIC ACID

SMILES

O[C@H]1[C@@H](C[C@@](O)(C[C@H]1OC(=O)\C=C\C2=CC(O)=C(O)C=C2)C(O)=O)OC(=O)\C=C\C3=CC(O)=C(O)C=C3

InChI

InChIKey=KRZBCHWVBQOTNZ-PSEXTPKNSA-N
InChI=1S/C25H24O12/c26-15-5-1-13(9-17(15)28)3-7-21(30)36-19-11-25(35,24(33)34)12-20(23(19)32)37-22(31)8-4-14-2-6-16(27)18(29)10-14/h1-10,19-20,23,26-29,32,35H,11-12H2,(H,33,34)/b7-3+,8-4+/t19-,20-,23-,25+/m1/s1

HIDE SMILES / InChI
Molecular Formula C25H24O12
Molecular Weight 516.4509
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 2
Optical Activity UNSPECIFIED

Description

3,5-Dicaffeoylquinic acid is an active component naturally occurring in many plants such as Helichrysum populifolium, Ipomoea batatas, Centella asiatica, Aster scaber and green coffee beans to name a few. It is a selective inhibitor of human immunodeficiency virus type 1 integrase and can be a promising agent for the treatment of patients with HIV infection.

Originator

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8297
 0.66 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Basic research
Unknown

Approved Use

Unknown
Primary
Preclinical
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase.
1996 Jun 25
A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals.
2005 Dec

Sample Use Guides

In Vivo Use Guide
In a preclinical model of Alzheimer’s disease, mice were orally administered with 3,5-dicaffeoylquinic acid mixed with drinking water (6.7 mg/kg/day) for 1 month using oral administration tube and syringe.
Route of Administration: Oral
In Vitro Use Guide
In a viability assay, SH-SY5Y cells were treated with 3,5-dicaffeoylquinic acid (20 uM) and exposed to 2 uM Abeta1-42 for 72 h. The drug was shown to protect the cells from death and the cell viability significantly increased to 106.5%.
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:54:05 UTC 2023
Edited
by admin
on Sat Dec 16 08:54:05 UTC 2023
Record UNII
ND94C5E75K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3,5-DI-O-CAFFEOYLQUINIC ACID
Common Name English
3,5-DI-O-(E)-CAFFEOYLQUINIC ACID
Common Name English
(1S,3R,4S,5R)-3,5-BIS(((E)-3-(3,4-DIHYDROXYPHENYL)ACRYLOYL)OXY)-1,5-DIHYDROXYCYCLOHEXANE-1-CARBOXYLIC ACID
Systematic Name English
CJ-4-16-4
Common Name English
(1.ALPHA.,3R,4.ALPHA.,5R)-3,5-BIS(((2E)-3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)OXY)-1,4-DIHYDROXYCYCLOHEXANECARBOXYLIC ACID
Systematic Name English
TRANS 3,5-O-DICAFFEOYLQUINIC ACID
Common Name English
CYCLOHEXANECARBOXYLIC ACID, 3,5-BIS(((2E)-3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)OXY)-1,4-DIHYDROXY-, (1.ALPHA.,3R,4.ALPHA.,5R)-
Systematic Name English
QUINIC ACID 3,5-DI-O-CAFFEATE
Common Name English
3,5-DICQA
Common Name English
(E,E)-3,5-DI-O-CAFFEOYLQUINIC ACID
Common Name English
3,5-DICAFFEOYLQUINIC ACID
Common Name English
CYCLOHEXANECARBOXYLIC ACID, 3,5-BIS((3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-1,4-DIHYDROXY-, (1R-(1.ALPHA.,3.ALPHA.(E),4.ALPHA.,5.BETA.(E)))-
Systematic Name English
3,5-DICAFFEOYLQUININIC ACID
Common Name English
(-)-3,5-DICAFFEOYLQUINIC ACID
Common Name English
CYCLOHEXANECARBOXYLIC ACID, 1,4-DIHYDROXY-3,5-BIS(((2E)-3-(4-HYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)OXY)-, (1.ALPHA.,3R,4.ALPHA.,5R)-
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID00424282
Created by admin on Sat Dec 16 08:54:06 UTC 2023 , Edited by admin on Sat Dec 16 08:54:06 UTC 2023
PRIMARY
CAS
900249-68-5
Created by admin on Sat Dec 16 08:54:06 UTC 2023 , Edited by admin on Sat Dec 16 08:54:06 UTC 2023
ALTERNATIVE
CAS
1245638-27-0
Created by admin on Sat Dec 16 08:54:06 UTC 2023 , Edited by admin on Sat Dec 16 08:54:06 UTC 2023
NON-SPECIFIC STEREOCHEMISTRY
RS_ITEM_NUM
1348033
Created by admin on Sat Dec 16 08:54:06 UTC 2023 , Edited by admin on Sat Dec 16 08:54:06 UTC 2023
PRIMARY
CAS
89919-62-0
Created by admin on Sat Dec 16 08:54:06 UTC 2023 , Edited by admin on Sat Dec 16 08:54:06 UTC 2023
PRIMARY
CHEBI
65751
Created by admin on Sat Dec 16 08:54:06 UTC 2023 , Edited by admin on Sat Dec 16 08:54:06 UTC 2023
PRIMARY
FDA UNII
ND94C5E75K
Created by admin on Sat Dec 16 08:54:06 UTC 2023 , Edited by admin on Sat Dec 16 08:54:06 UTC 2023
PRIMARY
CAS
2450-53-5
Created by admin on Sat Dec 16 08:54:06 UTC 2023 , Edited by admin on Sat Dec 16 08:54:06 UTC 2023
NON-SPECIFIC STEREOCHEMISTRY
Related Record Type Details
STEVIA REBAUDIUNA LEAF
PARENT -> CONSTITUENT ALWAYS PRESENT
Methanol extracts of stevia dry leaves were directly used for LC-MS analysis. Efficient separation and resolution were achieved with diphenyl packing and acetonitrile/water as solvent in the HPLC method. Negative ion mode was used for all MS measurements.
LONICERA JAPONICA FLOWER
PARENT -> CONSTITUENT ALWAYS PRESENT
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966